نتائج البحث - "Pistelli M."

1

دورية أكاديمية

Adjuvant capecitabine in triple negative breast cancer patients with residual disease after neoadjuvant treatment: real-world evidence from CaRe, a multicentric, observational study

المؤلفون: Di Lisa F. S., Krasniqi E., Pizzuti L., Barba M., Cannita K., De Giorgi U., Borella F., Foglietta J., Cariello A., Ferro A., Picardo E., Mitidieri M., Sini V., Stani S., Tonini G., Santini D., La Verde N., Gambaro A. R., Grassadonia A., Tinari N., Garrone O., Sarobba G., Livi L., Meattini I., D'Auria G., Vergati M., Gamucci T., Pistelli M., Berardi R., Risi E., Giotta F., Lorusso V., Rinaldi L., Artale S., Cazzaniga M. E., Zustovich F., Cappuzzo F., Landi L., Torrisi R., Scagnoli S., Botticelli A., Michelotti A., Fratini B., Saltarelli R., Paris I., Muratore M., Cassano A., Gianni L., Gaspari V., Veltri E. M., Zoratto F., Fiorio E., Fabbri M. A., Mazzotta M., Ruggeri E. M., Pedersini R., Valerio M. R., Filomeno L., Minelli M., Scavina P., Raffaele M., Astone A., De Vita R., Pozzi M., Riccardi F., Greco F., Moscetti L., Giordano M., Maugeri-Sacca M., Zennaro A., Botti C., Pelle F., Cappelli S., Cavicchi F., Vizza E., Sanguineti G., Tomao F., Cortesi E., Marchetti P., Tomao S., Speranza I., Sperduti I., Ciliberto G., Vici P.

المساهمون: Di Lisa F.S., Krasniqi E., Pizzuti L., Barba M., Cannita K., De Giorgi U., Borella F., Foglietta J., Cariello A., Ferro A., Picardo E., Mitidieri M., Sini V., Stani S., Tonini G., Santini D., La Verde N., Gambaro A.R., Grassadonia A., Tinari N., Garrone O., Sarobba G., Livi L., Meattini I., D'Auria G., Vergati M., Gamucci T., Pistelli M., Berardi R., Risi E., Giotta F., Lorusso V., Rinaldi L., Artale S., Cazzaniga M.E., Zustovich F., Cappuzzo F., Landi L., Torrisi R., Scagnoli S., Botticelli A., Michelotti A., Fratini B., Saltarelli R., Paris I., Muratore M., Cassano A., Gianni L., Gaspari V., Veltri E.M., Zoratto F., Fiorio E., Fabbri M.A., Mazzotta M., Ruggeri E.M., Pedersini R., Valerio M.R., Filomeno L., Minelli M., Scavina P., Raffaele M., Astone A., De Vita R., Pozzi M., Riccardi F., Greco F., Moscetti L., Giordano M., Maugeri-Sacca M., Zennaro A., Botti C., Pelle F., Cappelli S., Cavicchi F., Vizza E., Sanguineti G., Tomao F., Cortesi E., Marchetti P., Tomao S., Speranza I., Sperduti I., Ciliberto G., Vici P.

مصطلحات موضوعية: adjuvant capecitabine, neoadjuvant treatment, residual tumors, treatment discontinuation, triple negative breast cancer

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/37260975; info:eu-repo/semantics/altIdentifier/wos/WOS:000997057100001; volume:13; numberofpages:17; journal:FRONTIERS IN ONCOLOGY; https://hdl.handle.net/10447/596593Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85161078688

الإتاحة: https://doi.org/10.3389/fonc.2023.1152123Test
https://hdl.handle.net/10447/596593Test

View record in BASE

2

دورية أكاديمية

225P Platinum-based chemotherapy and PARP Inhibitors for BRCA mutated metastatic breast cancer (LATER-BC): Retrospective multicentre analysis of post-progression treatments

المؤلفون: Valenza, C., Trapani, D., Sposetti, C., Bielo, L. Boscolo, Marra, A., Giarratano, T., Cortesi, L., Moscetti, L., Pistelli, M., Berardi, R., Zambelli, A., Guarneri, V., Vernieri, C., Curigliano, G.

المصدر: ESMO Open ; volume 8, issue 1, page 101414 ; ISSN 2059-7029

مصطلحات موضوعية: Cancer Research, Oncology

الإتاحة: https://doi.org/10.1016/j.esmoop.2023.101414Test
https://api.elsevier.com/content/article/PII:S2059702923006403?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S2059702923006403?httpAccept=text/plainTest

View record in BASE

3

دورية أكاديمية

Prognostic significance of germline BRCA mutations in patients with HER2-POSITIVE breast cancer.

المؤلفون: Viansone A, Pellegrino B, Omarini C, Pistelli M, Boggiani D, Sikokis A, Uliana V, Zanoni D, Tommasi C, Bortesi B, Bonatti F, Piacentini F, Cortesi L, Camisa R, Sgargi P, Michiara M, Musolino A.

المساهمون: Viansone, A, Pellegrino, B, Omarini, C, Pistelli, M, Boggiani, D, Sikokis, A, Uliana, V, Zanoni, D, Tommasi, C, Bortesi, B, Bonatti, F, Piacentini, F, Cortesi, L, Camisa, R, Sgargi, P, Michiara, M, Musolino, A.

مصطلحات موضوعية: BRCA, Breast cancer, Germline mutation, HER2, Prognosi

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35970028; info:eu-repo/semantics/altIdentifier/wos/WOS:000888769600003; volume:65; firstpage:145; lastpage:150; journal:BREAST; http://hdl.handle.net/11380/1285650Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85135868427

الإتاحة: https://doi.org/10.1016/j.breast.2022.07.012Test
http://hdl.handle.net/11380/1285650Test

View record in BASE

4

دورية أكاديمية

Skills Demand in Energy Intensive Industries Targeting Industrial Symbiosis and Energy Efficiency

المؤلفون: Branca T. A., Fornai B., Colla V., Pistelli M. I., Faraci E. L., Cirilli F., Schroder A. J.

المساهمون: Branca, T. A., Fornai, B., Colla, V., Pistelli, M. I., Faraci, E. L., Cirilli, F., Schroder, A. J.

مصطلحات موضوعية: energy efficiency, energy intensive industrie, industrial symbiosi, training and education program, workforce

العلاقة: volume:14; issue:23; firstpage:15615; numberofpages:20; journal:SUSTAINABILITY; https://hdl.handle.net/11382/551191Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85143621743

الإتاحة: https://doi.org/10.3390/su142315615Test
https://hdl.handle.net/11382/551191Test

View record in BASE

5

دورية أكاديمية

The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial

المؤلفون: Pizzuti L., Barba M., Mazzotta M., Krasniqi E., Maugeri-Sacca M., Gamucci T., Berardi R., Livi L., Ficorella C., Natoli C., Cortesi E., Generali D., La Verde N., Cassano A., Bria E., Moscetti L., Michelotti A., Adamo V., Zamagni C., Tonini G., Sergi D., Marinelli D., Paoletti G., Tomao S., Botticelli A., Marchetti P., Tinari N., Grassadonia A., Valerio M. R., Mirabelli R., Fabbri M. A., D'Ostilio N., Veltri E., Corsi D., Garrone O., Paris I., Sarobba G., Meattini I., Pistelli M., Giotta F., Lorusso V., Garufi C., Russo A., Cazzaniga M., Del Medico P., Roselli M., Vaccaro A., Perracchio L., di Benedetto A., Daralioti T., Sperduti I., De Maria R., Di Leo A., Sanguineti G., Ciliberto G., Vici P.

المساهمون: Pizzuti, L., Barba, M., Mazzotta, M., Krasniqi, E., Maugeri-Sacca, M., Gamucci, T., Berardi, R., Livi, L., Ficorella, C., Natoli, C., Cortesi, E., Generali, D., La Verde, N., Cassano, A., Bria, E., Moscetti, L., Michelotti, A., Adamo, V., Zamagni, C., Tonini, G., Sergi, D., Marinelli, D., Paoletti, G., Tomao, S., Botticelli, A., Marchetti, P., Tinari, N., Grassadonia, A., Valerio, M. R., Mirabelli, R., Fabbri, M. A., D'Ostilio, N., Veltri, E., Corsi, D., Garrone, O., Paris, I., Sarobba, G., Meattini, I., Pistelli, M., Giotta, F., Lorusso, V., Garufi, C., Russo, A., Cazzaniga, M., Del Medico, P., Roselli, M., Vaccaro, A., Perracchio, L., di Benedetto, A., Daralioti, T., Sperduti, I., De Maria, R., Di Leo, A., Sanguineti, G., Ciliberto, G., Vici, P.

مصطلحات موضوعية: breast cancer, human epidermal growth factor receptor 2 (HER2), pertuzumab, trastuzumab-emtansine, estrogen, progesterone receptor

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34215766; info:eu-repo/semantics/altIdentifier/wos/WOS:000672163500003; volume:11; issue:1; journal:SCIENTIFIC REPORTS; https://hdl.handle.net/11573/1582762Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85109026282

الإتاحة: https://doi.org/10.1038/s41598-021-92774-zTest
https://hdl.handle.net/11573/1582762Test

View record in BASE

6

دورية أكاديمية

PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting

المؤلفون: Pizzuti L., Krasniqi E., Sperduti I., Barba M., Gamucci T., Mauri M., Veltri E. M., Meattini I., Berardi R., Di Lisa F. S., Natoli C., Pistelli M., Iezzi L., Risi E., D'Ostilio N., Tomao S., Ficorella C., Cannita K., Riccardi F., Cassano A., Bria E., Fabbri M. A., Mazzotta M., Barchiesi G., Botticelli A., D'Auria G., Ceribelli A., Michelotti A., Russo A., Salimbeni B. T., Sarobba G., Giotta F., Paris I., Saltarelli R., Marinelli D., Corsi D., Capomolla E. M., Sini V., Moscetti L., Mentuccia L., Tonini G., Raffaele M., Marchetti L., Minelli M., Ruggeri E. M., Scavina P., Bacciu O., Salesi N., Livi L., Tinari N., Grassadonia A., Fedele Scinto A., Rossi R., Valerio M. R., Landucci E., Stani S., Fratini B., Maugeri-Sacca M., De Tursi M., Maione A., Santini D., Orlandi A., Lorusso V., Cortesi E., Sanguineti G., Pinnaro P., Cappuzzo F., Landi L., Botti C., Tomao F., Cappelli S., Bon G., Pelle F., Cavicchi F., Fiorio E., Foglietta J., Scagnoli S., Marchetti P., Ciliberto G., Vici P.

المساهمون: Pizzuti, L., Krasniqi, E., Sperduti, I., Barba, M., Gamucci, T., Mauri, M., Veltri, E. M., Meattini, I., Berardi, R., Di Lisa, F. S., Natoli, C., Pistelli, M., Iezzi, L., Risi, E., D'Ostilio, N., Tomao, S., Ficorella, C., Cannita, K., Riccardi, F., Cassano, A., Bria, E., Fabbri, M. A., Mazzotta, M., Barchiesi, G., Botticelli, A., D'Auria, G., Ceribelli, A., Michelotti, A., Russo, A., Salimbeni, B. T., Sarobba, G., Giotta, F., Paris, I., Saltarelli, R., Marinelli, D., Corsi, D., Capomolla, E. M., Sini, V., Moscetti, L., Mentuccia, L., Tonini, G., Raffaele, M., Marchetti, L., Minelli, M., Ruggeri, E. M., Scavina, P., Bacciu, O., Salesi, N., Livi, L., Tinari, N., Grassadonia, A., Fedele Scinto, A., Rossi, R., Valerio, M. R., Landucci, E., Stani, S., Fratini, B., Maugeri-Sacca, M., De Tursi, M., Maione, A., Santini, D., Orlandi, A., Lorusso, V., Cortesi, E., Sanguineti, G., Pinnaro, P., Cappuzzo, F., Landi, L., Botti, C., Tomao, F., Cappelli, S., Bon, G., Pelle, F., Cavicchi, F., Fiorio, E., Foglietta, J., Scagnoli, S., Marchetti, P., Ciliberto, G., Vici, P.

مصطلحات موضوعية: advanced breast cancer, HER2-positive, lapatinib, pertuzumab, sequence, T-DM1

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35173816; info:eu-repo/semantics/altIdentifier/wos/WOS:000723874100003; volume:13; journal:THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY; http://hdl.handle.net/11573/1637023Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85120166745

الإتاحة: https://doi.org/10.1177/17588359211059873Test
http://hdl.handle.net/11573/1637023Test

View record in BASE

7

دورية أكاديمية

EFFECT: a randomized phase II study of efficacy and impact on function of two doses of nab-paclitaxel as first-line treatment in older women with advanced breast cancer

المؤلفون: Biganzoli L., Cinieri S., Berardi R., Pedersini R., McCartney A., Minisini A. M., Caremoli E. R., Spazzapan S., Magnolfi E., Brunello A., Risi E., Palumbo R., Leo S., Colleoni M., Donati S., De Placido S., Orlando L., Pistelli M., Parolin V., Mislang A., Becheri D., Puglisi F., Sanna G., Zafarana E., Boni L., Mottino G.

المساهمون: Biganzoli, L., Cinieri, S., Berardi, R., Pedersini, R., Mccartney, A., Minisini, A. M., Caremoli, E. R., Spazzapan, S., Magnolfi, E., Brunello, A., Risi, E., Palumbo, R., Leo, S., Colleoni, M., Donati, S., De Placido, S., Orlando, L., Pistelli, M., Parolin, V., Mislang, A., Becheri, D., Puglisi, F., Sanna, G., Zafarana, E., Boni, L., Mottino, G.

مصطلحات موضوعية: Breast cancer, Functional decline, Metastatic, Nab-paclitaxel, Older adult, Toxicity

العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000560788200001; volume:22; issue:1; firstpage:83; journal:BREAST CANCER RESEARCH; http://hdl.handle.net/11390/1189175Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85089170533

الإتاحة: https://doi.org/10.1186/s13058-020-01319-1Test
http://hdl.handle.net/11390/1189175Test

View record in BASE

8

دورية أكاديمية

Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies

المساهمون: Cazzaniga, M. E., Verusio, C., Ciccarese, M., Fumagalli, A., Sartori, D., Valerio, M. R., Airoldi, M., Moretti, G., Ficorella, C., Gianni, L., Michelotti, A., Zambelli, A., Febbraro, A., Generali, D., Pistelli, M., Garrone, O., Musolino, A., Vici, P., Maur, M., Mentuccia, L., La Verde, N., Bianchi, G. V., Artale, S., Blasi, L., De Laurentiis, M., Atzori, F., Turletti, A., Porpiglia, M., Santini, D., Fabi, A., Gebbia, V., Schirone, A., Palumbo, R., Ferzi, A., Frassoldati, A., Scavelli, C., Clivio, L., Giordano, M., Donadio, M., Biganzoli, L., Del Mastro, L., Bisagni, G., Livi, L., Natoli, C., Montemurro, F., Riccardi, F., Romagnoli, E., Marchetti, P., Torri, V., Pronzato, P., Mustacchi, G.

مصطلحات موضوعية: Advanced breast cancer, First-line setting, Fulvestrant, Hormone receptor positive

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/32231495; info:eu-repo/semantics/altIdentifier/wos/WOS:000522860200006; volume:15; issue:1; firstpage:30; lastpage:37; numberofpages:8; journal:BREAST CARE; https://hdl.handle.net/11368/3053219Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85064867292; https://karger.com/brc/article/15/1/30/52641/Is-There-Still-a-Role-for-Endocrine-Therapy-AloneTest; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098305Test/

الإتاحة: https://doi.org/10.1159/000495469Test
https://hdl.handle.net/11368/3053219Test
https://karger.com/brc/article/15/1/30/52641/Is-There-Still-a-Role-for-Endocrine-Therapy-AloneTest
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098305Test/

View record in BASE

9

دورية أكاديمية

Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting

المؤلفون: Pizzuti L, Krasniqi E, Barchiesi G, Della Giulia M, Izzo F, Sanguineti G, Marchetti P, Mazzotta M, Giusti R, Botticelli A, Gamucci T, Natoli C, Grassadonia A, Tinari N, Iezzi L, Tomao S, Tomao F, Tonini G, Santini D, Astone A, Michelotti A, De Angelis C, Mentuccia L, Vaccaro A, Magnolfi E, Gelibter A, Magri V, Cortesi E, D'Onofrio L, Cassano A, Rossi E, Cazzaniga M, Moscetti L, Omarini C, Piacentini F, Fabbri MA, Scinto AF, Corsi D, Carbognin L, Bria E, La Verde N, Samaritani R, Garufi C, Barni S, Mirabelli R, Sarmiento R, Veltri E, D'Auria G, Paris I, Giotta F, Lorusso V, Cardillo F, Landucci E, Mauri M, Ficorella C, Roselli M, Adamo V, Ricciardi GRR, Russo A, Berardi R, Pistelli M, Fiorio E, Cannita K, Sini V, D'Ostilio N, Foglietta J, Greco F, Zamagni C, Garrone O, Di Cocco B, Baldini E, Livi L, Desideri I, Meattini I, Sarobba G, Del Medico P, De Tursi M, Generali D, De Maria R, Risi E, Ciliberto G, Sperduti I, Villa A, Barba M, Di Leo A, Vici P.

المساهمون: Pizzuti, L, Krasniqi, E, Barchiesi, G, Della Giulia, M, Izzo, F, Sanguineti, G, Marchetti, P, Mazzotta, M, Giusti, R, Botticelli, A, Gamucci, T, Natoli, C, Grassadonia, A, Tinari, N, Iezzi, L, Tomao, S, Tomao, F, Tonini, G, Santini, D, Astone, A, Michelotti, A, De Angelis, C, Mentuccia, L, Vaccaro, A, Magnolfi, E, Gelibter, A, Magri, V, Cortesi, E, D'Onofrio, L, Cassano, A, Rossi, E, Cazzaniga, M, Moscetti, L, Omarini, C, Piacentini, F, Fabbri, Ma, Scinto, Af, Corsi, D, Carbognin, L, Bria, E, La Verde, N, Samaritani, R, Garufi, C, Barni, S, Mirabelli, R, Sarmiento, R, Veltri, E, D'Auria, G, Paris, I, Giotta, F, Lorusso, V, Cardillo, F, Landucci, E, Mauri, M, Ficorella, C, Roselli, M, Adamo, V, Ricciardi, Grr, Russo, A, Berardi, R, Pistelli, M, Fiorio, E, Cannita, K, Sini, V, D'Ostilio, N, Foglietta, J, Greco, F, Zamagni, C, Garrone, O, Di Cocco, B, Baldini, E, Livi, L, Desideri, I, Meattini, I, Sarobba, G, Del Medico, P, De Tursi, M, Generali, D, De Maria, R, Risi, E, Ciliberto, G, Sperduti, I, Villa, A, Barba, M, Di Leo, A, Vici, P.

مصطلحات موضوعية: HER2 positive, T-DM1, advanced breast cancer, pertuzumab, real world, trastuzumab

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/31330065; info:eu-repo/semantics/altIdentifier/wos/WOS:000480304500001; volume:146; issue:7; firstpage:1917; lastpage:1929; numberofpages:13; journal:INTERNATIONAL JOURNAL OF CANCER; http://hdl.handle.net/11380/1179582Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85070751994

الإتاحة: https://doi.org/10.1002/ijc.32583Test
http://hdl.handle.net/11380/1179582Test

View record in BASE

10

دورية أكاديمية

1609P COVID-19 outbreak repercussions on breast cancer diagnoses and access to treatment: Preliminary data from the COVID-DELAY study

المؤلفون: Berardi, R., Mentrasti, G., Crocetti, S., La Verde, N., Chiari, R., Cona, M.S., Nicolardi, L., De Filippis, C., Oldani, S., Pecci, F., Venanzi, F., Rocchi, M.B.L., Savini, A., Cantini, L., Pistelli, M.

المصدر: Annals of Oncology ; volume 32, page S1149 ; ISSN 0923-7534

مصطلحات موضوعية: Oncology, Hematology

الإتاحة: https://doi.org/10.1016/j.annonc.2021.08.1602Test
https://api.elsevier.com/content/article/PII:S092375342103831X?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S092375342103831X?httpAccept=text/plainTest

View record in BASE

تنقيح النتائج